Dialene, Justene Brent .
HRN: 23-82-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/02/2023
10/08/2023
IVT
300mg
Q8
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes